Cargando…
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data
This retrospective observational study aimed to gain a better understanding of the protective duration of prior SARS-CoV-2 infection against reinfection. The objectives were two-fold: to assess the durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previou...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045607/ https://www.ncbi.nlm.nih.gov/pubmed/36943829 http://dx.doi.org/10.1371/journal.pone.0280584 |
_version_ | 1784913646133968896 |
---|---|
author | Reynolds, Shannon L. Kaufman, Harvey W. Meyer, William A. Bush, Chris Cohen, Oren Cronin, Kathy Kabelac, Carly Leonard, Sandy Anderson, Steve Petkov, Valentina Lowy, Douglas Sharpless, Norman Penberthy, Lynne |
author_facet | Reynolds, Shannon L. Kaufman, Harvey W. Meyer, William A. Bush, Chris Cohen, Oren Cronin, Kathy Kabelac, Carly Leonard, Sandy Anderson, Steve Petkov, Valentina Lowy, Douglas Sharpless, Norman Penberthy, Lynne |
author_sort | Reynolds, Shannon L. |
collection | PubMed |
description | This retrospective observational study aimed to gain a better understanding of the protective duration of prior SARS-CoV-2 infection against reinfection. The objectives were two-fold: to assess the durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection, and to evaluate the crude SARS-CoV-2 reinfection rate and associated risk factors. During the pandemic era time period from February 29, 2020, through April 30, 2021, 144,678,382 individuals with SARS-CoV-2 molecular diagnostic or antibody test results were studied. Rates of reinfection among index-positive individuals were compared to rates of infection among index-negative individuals. Factors associated with reinfection were evaluated using multivariable logistic regression. For both objectives, the outcome was a subsequent positive molecular diagnostic test result. Consistent with prior findings, the risk of reinfection among index-positive individuals was 87% lower than the risk of infection among index-negative individuals. The duration of protection against reinfection was stable over the median 5 months and up to 1-year follow-up interval. Factors associated with an increased reinfection risk included older age, comorbid immunologic conditions, and living in congregate care settings; healthcare workers had a decreased reinfection risk. This large US population-based study suggests that infection induced immunity is durable for variants circulating pre-Delta predominance. |
format | Online Article Text |
id | pubmed-10045607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-100456072023-03-29 Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data Reynolds, Shannon L. Kaufman, Harvey W. Meyer, William A. Bush, Chris Cohen, Oren Cronin, Kathy Kabelac, Carly Leonard, Sandy Anderson, Steve Petkov, Valentina Lowy, Douglas Sharpless, Norman Penberthy, Lynne PLoS One Research Article This retrospective observational study aimed to gain a better understanding of the protective duration of prior SARS-CoV-2 infection against reinfection. The objectives were two-fold: to assess the durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection, and to evaluate the crude SARS-CoV-2 reinfection rate and associated risk factors. During the pandemic era time period from February 29, 2020, through April 30, 2021, 144,678,382 individuals with SARS-CoV-2 molecular diagnostic or antibody test results were studied. Rates of reinfection among index-positive individuals were compared to rates of infection among index-negative individuals. Factors associated with reinfection were evaluated using multivariable logistic regression. For both objectives, the outcome was a subsequent positive molecular diagnostic test result. Consistent with prior findings, the risk of reinfection among index-positive individuals was 87% lower than the risk of infection among index-negative individuals. The duration of protection against reinfection was stable over the median 5 months and up to 1-year follow-up interval. Factors associated with an increased reinfection risk included older age, comorbid immunologic conditions, and living in congregate care settings; healthcare workers had a decreased reinfection risk. This large US population-based study suggests that infection induced immunity is durable for variants circulating pre-Delta predominance. Public Library of Science 2023-03-21 /pmc/articles/PMC10045607/ /pubmed/36943829 http://dx.doi.org/10.1371/journal.pone.0280584 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Reynolds, Shannon L. Kaufman, Harvey W. Meyer, William A. Bush, Chris Cohen, Oren Cronin, Kathy Kabelac, Carly Leonard, Sandy Anderson, Steve Petkov, Valentina Lowy, Douglas Sharpless, Norman Penberthy, Lynne Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data |
title | Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data |
title_full | Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data |
title_fullStr | Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data |
title_full_unstemmed | Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data |
title_short | Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data |
title_sort | risk of and duration of protection from sars-cov-2 reinfection assessed with real-world data |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045607/ https://www.ncbi.nlm.nih.gov/pubmed/36943829 http://dx.doi.org/10.1371/journal.pone.0280584 |
work_keys_str_mv | AT reynoldsshannonl riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT kaufmanharveyw riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT meyerwilliama riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT bushchris riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT cohenoren riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT croninkathy riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT kabelaccarly riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT leonardsandy riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT andersonsteve riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT petkovvalentina riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT lowydouglas riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT sharplessnorman riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata AT penberthylynne riskofanddurationofprotectionfromsarscov2reinfectionassessedwithrealworlddata |